The Genomic Medicine Revolution
Genomic medicines already have favorable risk/reward profiles, and improved manufacturing processes could cut costs and increase adoption. By Arelis Agosto
Thoroughly researched perspectives and commentary on the trends shaping global markets. Subscribe to Updates →
Exploring a range of subjects as diverse as our product lineup.
Genomic medicines already have favorable risk/reward profiles, and improved manufacturing processes could cut costs and increase adoption. By Arelis Agosto
AI is poised to render longstanding healthcare inefficiencies a thing of the past, potentially paving the way for lower costs and better ... By Arelis Agosto
Attending Vox Media’s annual Code Conference offered a glimpse into the future, and the overarching theme was artificial intelligence. By Global X Team
Healthcare innovation fueled by genomics, telemedicine, and AI's potential, presents compelling opportunities for investors. By Global X Team
An aging population increases demand for advanced and affordable healthcare, creating long-term investment opportunities in genomics and telemedicines. By Global X Team
Inefficiencies in the healthcare space could potentially create a large opportunity for companies using modern tech to cut costs and improve patient ... By Global X Team
In March 2023, Global X Research surveyed 1,032 individuals in the United States regarding their openness to and reservations regarding digital health ... By Global X Team
In February 2023, Global X Research surveyed 302 individuals in the United States regarding their reservations and expectations concerning generative artificial intelligence ... By Global X Team
On Facebook’s Q2 2021 earnings call, CEO Mark Zuckerberg and others mentioned the metaverse 20 different times. Roblox mentioned the metaverse 16 ... By Pedro Palandrani
The following is part 2 in 3-part blog series on the global cannabis industry. This part takes the pulse of existing cannabis ... By Global X Team
In October 2022, Global X Research surveyed 297 individuals in the United States regarding their status on, preferences for, and perceived changes ... By Global X Team
In September 2022, Global X Research surveyed 307 individuals in the United States regarding their status on, preferences for, and perceived changes ... By Global X Team
In April 2022, we surveyed 621 individuals in the United States on their investing viewpoints, attuned to generational differences. The purpose of ... By Global X Team
Inflation and rising interest rates create an uphill journey for the consumer and the economy. U.S. real disposable income has been declining ... By Jon Maier; Michelle Cluver, CFA
Patience can be a virtue in the genomic space, as next-generation biotech treatments don’t hit the market overnight. However, when all the ... By Global X Team
A look at ongoing legislative policy and its expected impact on the Telemedicine & Digital Health space. By Global X Team
The showroom floor at CES 2022 was quieter than in previous years with many companies canceling their on-site presentations due to omicron. ... By Global X Team
How does the social commerce phenomenon leverage social networking to completely transform the e-commerce landscape? By Global X Team
2020 was a watershed year for global cannabis markets despite the backdrop of COVID-19. By Global X Research Team
The following is part 2 in 3-part blog series on the global cannabis industry. This part takes the pulse of existing cannabis ... By Global X Team
2020 was a landmark year for the state-level cannabis industry in the U.S. and 2021 is shaping up to be one as ... By Global X Research Team
FinTech’s scope continues to increase. As it grows, we believe investors should broaden their view of FinTech. By Pedro Palandrani
A look at four companies in the rapidly emerging field of Telemedicine & Digital Health. By Global X Team
In this piece, we explore the trends that we believe are driving significant opportunity in Telemedicine and Digital Health. By Global X Team
Beyond simply playing a game, the four companies we highlight here exemplify the ongoing transformation of the industry. By Pedro Palandrani
With most of the internet-connected world already on social media, these platforms now focus on maximizing the revenue generated from each user By Pedro Palandrani
In this piece, we explore what the 2020 console upgrade cycle means for the industry and how cloud gaming may support positive ... By Pedro Palandrani
In this piece, we review major innovations over the last decade and anticipate what revolutionary changes may be in store for us ... By Pedro Palandrani
TERMS OF USE
Global X Brasil Gestora de Investimentos Ltda. (“Global X Brasil”) is an asset manager authorized by the Brazilian Securities and Exchange Commission (“CVM”), constituted in the form of CVM Resolution No. 21/2021. Investing involves risks. The material on this site is for informational purposes only and does not constitute investment advice, recommendation, offer or solicitation to buy or sell any securities, funds, or strategies to any person in any jurisdiction in which an offer, solicitation, purchase, or sale would be illegal under the securities laws of such jurisdiction. Opinions expressed here are subject to change without notice. Reliance upon the information contained in this material is at the sole discretion of the reader. No securities regulator has confirmed the accuracy of any information contained herein. Access to the information on this site or the use of the services or information provided herein is prohibited by any person or entity in any jurisdiction or country where such distribution or use is contrary to local law, rules, or regulation. Investment in index funds (ETFs) involves risks, including detachment from the benchmark index and related to the liquidity of shares in the secondary market. Investment funds managed by Global X Brasil use strategies that can result in significant equity losses for their quota holders. Global X Brasil, its partners and employees are exempt of responsibility for any damages resulting directly or indirectly from the use of the information contained on this website.
FOR EVALUATION OF THE PERFORMANCE OF AN INVESTMENT FUND, IT IS RECOMMENDED THE ANALYSIS OF AT LEAST 12 (TWELVE) MONTHS. INVESTMENT FUNDS DO NOT HAVE A GUARANTEE FROM THE ADMINISTRATOR, THE MANAGER, ANY INSURANCE MECHANISM OR CREDIT GUARANTEE FUND – FGC. INVESTMENTS IN FINANCIAL AND CAPITAL MARKETS ARE SUBJECT TO RISKS OF LOSS GREATER THAN THE TOTAL VALUE OF INVESTED CAPITAL. PAST PROFITABILITY DOES NOT REPRESENT A GUARANTEE OF FUTURE PROFITABILITY THE PROFITABILITY DISCLOSED IS NOT NET OF TAXES. READ THE PROSPECTUS, THE FORM OF COMPLEMENTARY INFORMATION, SHEET OF ESSENTIAL INFORMATION AND THE REGULATION BEFORE INVESTING. DESCRIPTION OF THE ANBIMA TYPE AVAILABLE IN THE FORM OF COMPLEMENTARY INFORMATION.